Kinzler, Maximilian N. https://orcid.org/0000-0003-2378-1455
Metzger, Eric https://orcid.org/0000-0002-1394-1083
Schulz, Rebecca
Bankov, Katrin
Ramos-Triguero, Anna https://orcid.org/0009-0004-0031-4103
Schulze, Falko
Gretser, Steffen
Abedin, Nada
Wiegering, Armin
Zeuzem, Stefan https://orcid.org/0000-0002-0845-6833
Walter, Dirk https://orcid.org/0000-0003-2309-9624
Reis, Henning https://orcid.org/0000-0003-1373-5295
Schüle, Roland
Wild, Peter J.
Funding for this research was provided by:
Universitätsklinikum Frankfurt
Article History
Received: 12 February 2025
Accepted: 25 April 2025
First Online: 13 May 2025
Declarations
:
: The study protocol was approved by the institutional Review Boards of the UCT and the Ethical Committee at the University Hospital Frankfurt (project-number: UCT-27-2022_A2022). The study was performed in accordance with the Declaration of Helsinki.
: Patients provided informed written consent and patient data was provided after approval by the local ethics committee.
: Not applicable.
: S. Z.: Consultancy and/or speaker’s bureau: Abbvie, Boehringer Ingelheim, Gilead, GSK, Ipsen, Madrigal, MSD, NovoNordisk; H.R.: Received honoraria from Astellas, Astra-Zeneca, Bristol-Myers Squibb, Boehringer-Ingelheim, CHOP GmbH, Diaceutics, Evidia, GlaxoSmithKline, HUeG e.V., Janssen-Cilag, Klinikum Wolfsburg, MCI, Menarini Stemline, Merck, Novartis, Roche, Sanofi, and Takeda, and received travel support from Philips, Roche, and Bristol-Myers Squibb, and received grants from Bristol-Myers Squibb, and holds shares of AstraZeneca. P.J.W.: Consulting fees and honoraria for lectures from Bayer, Sanofi, Novartis, Roche, MSD, Astellas Pharma, Bristol-Myers Squibb, Thermo Fisher Scientific, Molecular Health, Guardant Health, Eli Lilly, Menarini Group, Myriad, Hedera Dx, and AstraZeneca. Research support was provided by AstraZeneca, iOMEDICO, and Roche. The authors declare that there is no relationship relevant to the manuscripts’ subject. All other authors declare no conflicts of interest.